We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
-4.59%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$2.54B
AUM Growth
-$715M
(-22%)
Cap. Flow
-$518M
Cap. Flow
% of AUM
-20.43%
Top 10 Holdings %
Top 10 Hldgs %
29.56%
Holding
814
New
64
Increased
137
Reduced
258
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$25.3M |
| 2 |
Pfizer
PFE
|
+$20.7M |
| 3 |
Paychex
PAYX
|
+$11.6M |
| 4 |
Expedia Group
EXPE
|
+$10.9M |
| 5 |
United Parcel Service
UPS
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$243M |
| 2 |
Amazon
AMZN
|
+$130M |
| 3 |
Teradyne
TER
|
+$30.1M |
| 4 |
Target
TGT
|
+$28.4M |
| 5 |
Advanced Micro Devices
AMD
|
+$25.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.5% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Communication Services | 10.21% |
| 5 | Financials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Lantronix
LTRX
$262M
| $529K | 0.02% |
79,100
-39,402
| -33% | -$280K |
|
377
Appian
APPN
$2.51B
| $525K | 0.02% |
8,622
+4,355
| +102% | +$247K |
|
378
SiTime
SITM
$21.4B
| $525K | 0.02% |
2,122
| – | – |
|
379
ANI Pharmaceuticals
ANIP
$1.71B
| $524K | 0.02% |
18,643
-2,953
| -14% | -$110K |
|
380
MKS Inc
MKSI
$20.2B
| $517K | 0.02% |
3,444
-32,500
| -90% | -$5.05M |
|
|
OLO
381
DELISTED
Olo Inc
OLO
| $516K | 0.02% |
38,994
-21
| -0.1% | -$325 |
|
|
VTLE
382
DELISTED
Vital Energy
VTLE
| $506K | 0.02% |
+6,400
| New | +$464K |
|
383
Regenxbio
RGNX
$694M
| $504K | 0.02% |
15,168
+5,818
| +62% | +$162K |
|
384
Xencor
XNCR
$1.57B
| $504K | 0.02% |
18,870
| – | – |
|
385
Eldorado Gold
EGO
$10.2B
| $493K | 0.02% |
44,050
-5,350
| -11% | -$54.8K |
|
|
SEM
386
DELISTED
Select Medical
SEM
| $491K | 0.02% |
37,961
-283,381
| -88% | -$3.74M |
|
387
Organogenesis Holdings
ORGO
$246M
| $490K | 0.02% |
64,427
+22,226
| +53% | +$172K |
|
388
Concentrix
CNXC
$1.56B
| $489K | 0.02% |
2,937
-2
| -0.1% | -$380 |
|
389
Itaú Unibanco
ITUB
$87.4B
| $487K | 0.02% |
96,532
| – | – |
|
390
Aecom
ACM
$9.82B
| $486K | 0.02% |
6,336
-5
| -0.1% | -$367 |
|
391
Fulgent Genetics
FLGT
$526M
| $485K | 0.02% |
7,767
+2,023
| +35% | +$133K |
|
392
Aldeyra Therapeutics
ALDX
$92.3M
| $480K | 0.02% |
108,000
-15,200
| -12% | -$60.5K |
|
393
Prestige Consumer Healthcare
PBH
$2.52B
| $478K | 0.02% |
9,038
-6
| -0.1% | -$346 |
|
394
Ranpak Holdings
PACK
$457M
| $470K | 0.02% |
23,000
-3,100
| -12% | -$80.8K |
|
395
Sensus Healthcare
SRTS
$50.9M
| $469K | 0.02% |
+46,300
| New | +$423K |
|
396
MarineMax
HZO
$1.15B
| $467K | 0.02% |
11,600
-2,000
| -15% | -$94K |
|
|
ITCI
397
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $467K | 0.02% |
+7,633
| New | +$396K |
|
398
The ONE Group
STKS
$54.9M
| $465K | 0.02% |
44,173
-6,000
| -12% | -$70.5K |
|
399
Rithm Capital
RITM
$5.61B
| $464K | 0.02% |
42,253
-46
| -0.1% | -$488 |
|
400
iRadimed
IRMD
$1.18B
| $463K | 0.02% |
10,322
+10,300
| +46,818% | +$476K |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, ClariVest Asset Management held 814 positions worth $2.54B, down 22% from $3.25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ClariVest Asset Management withdrew a net $518M in Q1 2022, closing 125 positions and reducing 258 holdings. Its most notable exit was Apple, an estimated $243M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, ClariVest Asset Management opened a new position in Paychex worth $12.9M.
- ClariVest Asset Management's largest Q1 2022 buy was Paychex: 94,495 shares worth $12.9M.
- ClariVest Asset Management added most to Cadence Design Systems in Q1 2022, an estimated $25.3M increase.
- ClariVest Asset Management's biggest Q1 2022 reduction was Teradyne, cutting an estimated $30.1M.
- ClariVest Asset Management fully exited Apple in Q1 2022, selling an estimated $243M.
- ClariVest Asset Management's ten largest holdings make up 30% of its $2.54B portfolio in Q1 2022.
- ClariVest Asset Management opened 64 new positions and closed 125 in Q1 2022.
- ClariVest Asset Management's portfolio value fell 22% quarter-over-quarter to $2.54B.
Based on ClariVest Asset Management's 13F filing for Q1 2022, filed 4 May 2022.